Total Leishmania antigens with Poly(I:C) induce Th1 protective response.

about

Total Leishmania antigens with Poly(I:C) induce Th1 protective response.

Item

http://www.wikidata.org/entity/Q40049613

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Total Leishmania antigens with Poly(I:C) induce Th1 protective response.

@en

type

Item

label

Total Leishmania antigens with Poly(I:C) induce Th1 protective response.

@en

prefLabel

Total Leishmania antigens with Poly(I:C) induce Th1 protective response.

@en

P1476

Total Leishmania antigens with Poly(I:C) induce Th1 protective response.

@en

P2093

D E Cargnelutti

http://www.w3.org/2001/XMLSchema#string

E A Scodeller

http://www.w3.org/2001/XMLSchema#string

M C Salomón

http://www.w3.org/2001/XMLSchema#string

M J Germanó

http://www.w3.org/2001/XMLSchema#string

M S Di Genaro

http://www.w3.org/2001/XMLSchema#string

R J Eliçabe

http://www.w3.org/2001/XMLSchema#string

S Gea

http://www.w3.org/2001/XMLSchema#string

P2860

Leishmaniasis worldwide and global estimates of its incidence

Adjuvants: Classification, Modus Operandi, and Licensing

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.

Vaccines to prevent leishmaniasis.

Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.

The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice

Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice.

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant.

Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends.

P31

scholarly article

P356

10.1111/PIM.12491

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

María Fernanda García Bustos

M V Sanchez

P577

2017-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28901553

http://www.w3.org/2001/XMLSchema#string